BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 2 filers reported holding BRIDGEBIO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,994,653 | +150.7% | 75,641 | +63.5% | 0.00% | +200.0% |
| Q2 2023 | $795,724 | -65.0% | 46,263 | -66.2% | 0.00% | -66.7% |
| Q1 2023 | $2,270,514 | +616.6% | 136,943 | +229.4% | 0.00% | – |
| Q4 2022 | $316,824 | -23.3% | 41,578 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $413,285 | +9.3% | 41,578 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $378,000 | -10.4% | 41,578 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $422,000 | -39.2% | 41,578 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $694,000 | -64.8% | 41,578 | -1.1% | 0.00% | -75.0% |
| Q3 2021 | $1,971,000 | -23.7% | 42,060 | -0.8% | 0.00% | -20.0% |
| Q2 2021 | $2,583,000 | +1.6% | 42,379 | +2.7% | 0.01% | 0.0% |
| Q1 2021 | $2,543,000 | +12.9% | 41,278 | +30.3% | 0.01% | 0.0% |
| Q4 2020 | $2,253,000 | +139.7% | 31,688 | +26.5% | 0.01% | +150.0% |
| Q3 2020 | $940,000 | +12.0% | 25,042 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $839,000 | -21.9% | 25,717 | -30.6% | 0.00% | -33.3% |
| Q1 2020 | $1,074,000 | +182.6% | 37,038 | +241.7% | 0.00% | +200.0% |
| Q4 2019 | $380,000 | – | 10,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $373,797,000 | 67.28% |
| Darwin Global Management, Ltd. | 2,090,149 | $128,753,000 | 25.21% |
| Affinity Asset Advisors, LLC | 577,500 | $35,574,000 | 12.08% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $1,913,356,000 | 9.64% |
| Perceptive Advisors | 7,756,928 | $477,827,000 | 6.04% |
| Opaleye Management Inc. | 583,767 | $35,960,000 | 5.28% |
| MIZUHO MARKETS AMERICAS LLC | 171,923 | $10,590,000 | 4.93% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $1,639,853,000 | 4.88% |
| Fernwood Investment Management, LLC | 151,085 | $9,307,000 | 3.42% |
| HHLR ADVISORS, LTD. | 5,362,014 | $330,300,000 | 3.26% |